GE HealthCare's pocket ultrasound now coaches beginners through a lung scan

GE HealthCare announced on Tuesday, Nov. 3, 2026, two FDA 510(k)-cleared, CE-marked AI tools for its Vscan Air handheld ultrasound: Lung Guidance for point-of-care lung exams and AutoAS for spotting aortic stenosis.

Handheld ultrasound has been cheap enough for years; the bottleneck is that reading lungs and heart valves takes training most frontline clinicians don't have. If software can get a novice within two points of an expert on a lung exam, the probe stops being a specialist's tool and becomes an ER, ambulance and clinic tool. "Descriptive assessment" is doing some quiet work in that 95.2% though, so expect independent studies to be the real test.

Lung Guidance gives real-time probe guidance across an 8-zone lung protocol. A protocol, here, is a set order of places to look, eight zones on the lungs. The software detects the pleural line, A-lines, rib shadows, the diaphragm, and the abdomen. The pleural line is the bright boundary where the lung meets the chest wall. A-lines are repeating horizontal echoes that usually mean the lung underneath is full of air. It also includes AutoCapture, Save Best Clip, B-line detection and scoring, and reporting. A B-line is a vertical streak on the image that clinicians watch as a sign of fluid. Those features are GE HealthCare's.

In GE HealthCare's validation, which the company calls a descriptive assessment, non-expert users succeeded 95.2% of the time, compared with 96.8% for experts. A descriptive assessment is the company's own account of how the test went. It is not a separate group's trial. About 95 successful scans out of 100 for people who are not specialists, against about 97 out of 100 for experts, is what those two percentages mean. Those rates are GE HealthCare's.

AutoAS, on the Vscan Air SL, estimates whether a patient has moderate-to-severe aortic stenosis from at least two of three heart views, PLAX, PSAX-AV, or AP5, and shows a confidence score. Aortic stenosis is a narrowed aortic valve, the valve blood passes through on its way out of the heart. Those three labels are standard windows for aiming the probe: a long-axis view from beside the breastbone, a short-axis view of the aortic valve, and a five-chamber view from the tip of the heart. The tool was trained and validated against a panel of expert cardiologists. It is a diagnostic aid, not a standalone diagnosis. Those lines are GE HealthCare's.

Both tools are FDA 510(k) cleared and CE marked. A 510(k) clearance means the FDA accepted the tool as comparable to a device already on the market. CE marking is the European mark for sale in that market. They are sold through Vscan Air Innovation Packages in the United States and select countries. Existing customers get the updates by the end of November 2026. Those lines are GE HealthCare's.

They join the existing Vscan Air AI suite, which already includes Caption AI, Caption Interpretation Auto EF, and Auto Bladder Volume. Auto EF estimates ejection fraction, the share of blood the left ventricle pushes out with each beat. Those names are GE HealthCare's.

The picture is the Vscan Air Lung Guidance screen during a scan of lung zone L4: a live ultrasound image labeled Abdomen and Diaphragm, a probe-position guide on a body diagram, and a B-line score indicator. The credit is GE HealthCare.

In plain terms, GE HealthCare's pocket ultrasound now coaches a beginner through an eight-zone lung scan, and in the company's own test non-experts succeeded 95.2% of the time against 96.8% for experts. A second tool, AutoAS, flags likely moderate-to-severe aortic stenosis and shows a confidence score. Both are cleared. Neither one is a diagnosis by itself.